JD Supra
Purdue Stops at the Border? Chapter 15 and Foreign Plan Releases
When the Supreme Court decided Harrington v. Purdue Pharma L.P., many assumed the era of nonconsensual third-party releases ...
Purdue Pharma, McKinsey Net Court Approval of Bankruptcy Deal
Purdue Pharma secured court approval for a $125 million settlement with McKinsey & Co. to resolve claims related to the firm’s advisory role in marketing the drugmaker’s opioids.
Purdue Pharma dissolves in bankruptcy, names board of nonprofit successor
By Dietrich Knauth NEW YORK, May 1 (Reuters) - Purdue Pharma said on Friday that it has ceased operations and concluded its ...
SCOTUSblog
Harrington v. Purdue Pharma L.P.
Type to search articles, cases, and authors. Press ↵ to view all results. The bankruptcy code does not authorize a release and injunction that, as part of a plan of reorganization under Chapter 11, ...
The post-Purdue landscape: Navigating nonconsensual third-party releases through Chapter 15
Justin Winerman of BCLP explains that nonconsensual third-party releases remain available under Chapter 15, despite the ...
Opioid maker Purdue Pharma shuts down as part of $7.4 billion deal
Purdue Pharma, the bankrupted drug manufacturer at the center of the nation’s yearslong opioid epidemic, shut down May 1. The ...
Hosted on MSN
Purdue Pharma sentenced ahead of bankruptcy as judge hears "heartbreaking" testimonies
Newark, New Jersey - A federal judge on Tuesday criminally sentenced OxyContin-maker Purdue Pharma over its role in the opioid crisis, ahead of upcoming bankruptcy proceedings and its dissolution.